Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has successfully convened its 2024 first extraordinary general meeting, where shareholders voted on key resolutions and witnessed the election of a new non-executive director. The meeting saw a significant turnout with over 40% of shares with voting rights represented. Compliance with legal requirements and the presence of scrutineers ensured the integrity of the voting process.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.
